Drug-Induced Anaphylaxis

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO-ELSEVIER INC
Citação
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, v.37, n.4, p.629-0, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Drugs are among the main triggers of anaphylaxis, but identification of the culprit drug is frequently difficult. To confirm diagnosis of the causative agent, medical records and clinical history are fundamental. There are a few in vitro tests available in clinical practice, such as serum-specific IgE and basophil activation test. Skin tests are often useful for the diagnosis, although drug challenge is indicated in patients with inconclusive clinical history or to provide safe alternatives. Treatment of anaphylaxis is standard and intramuscular epinephrine is the main agent to prevent morbidity and mortality. Rapid desensitization may be indicated in selected cases.
Palavras-chave
Anaphylaxis, Drug allergy, Adverse drug reactions, Hypersensitivity, Nonsteroidal anti-inflammatory drugs, Epinephrine
Referências
  1. Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x
  2. Aranda A, 2011, ALLERGY, V66, P247, DOI 10.1111/j.1398-9995.2010.02460.x
  3. Aun MV, 2014, J ALLER CL IMM-PRACT, V2, P414, DOI 10.1016/j.jaip.2014.03.014
  4. Aun MV, 2011, ALLERGY ASTHMA PROC, V32, P301, DOI 10.2500/aap.2011.32.3450
  5. Ayuso P, 2013, CLIN EXP ALLERGY, V43, P1097, DOI 10.1111/cea.12140
  6. Blatman KSH, 2017, J ALLER CL IMM-PRACT, V5, P587, DOI 10.1016/j.jaip.2017.03.016
  7. Bonadonna P, 2014, IMMUNOL ALLERGY CLIN, V34, P397, DOI 10.1016/j.iac.2014.01.014
  8. Bonamichi-Santos R, 2016, CURR PHARM DESIGN, V22, P6870, DOI 10.2174/1381612822666161025154506
  9. Brennan PJ, 2009, J ALLERGY CLIN IMMUN, V124, P1259, DOI 10.1016/j.jaci.2009.09.009
  10. Brockow K, 2013, ALLERGY, V68, P702, DOI 10.1111/all.12142
  11. Caiado J, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0515-3
  12. Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P76, DOI 10.1016/j.jaip.2014.06.007
  13. Castells MC, 2015, J ALLER CL IMM-PRACT, V3, P350, DOI 10.1016/j.jaip.2015.03.015
  14. Decuyper II, 2017, DRUGS R&D, V17, P265, DOI 10.1007/s40268-017-0176-x
  15. Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350
  16. Ensina LF, 2014, J ALLER CL IMM-PRACT, V2, P825, DOI 10.1016/j.jaip.2014.08.016
  17. Faria E, 2014, J INVEST ALLERG CLIN, V24, P40
  18. Galvao VR, 2015, J ALLER CL IMM-PRACT, V3, P175, DOI 10.1016/j.jaip.2014.12.006
  19. Galvao VR, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0452-6
  20. Gaspar Ângela, 2012, Rev Port Imunoalergologia, V20, P173
  21. Giavina-Bianchi P, 2017, J ALLER CL IMM-PRACT, V5, P728, DOI 10.1016/j.jaip.2016.11.006
  22. Giavina-Bianchi P, 2017, J ALLER CL IMM-PRACT, V5, P593, DOI 10.1016/j.jaip.2017.03.015
  23. Giavina-Bianchi P, 2016, CURR OPIN ALLERGY CL, V16, P323, DOI 10.1097/ACI.0000000000000292
  24. Giavina-Bianchi P, 2015, CURR TREAT OPTIONS A, V2, P268
  25. Gonzalez-Estrada A, 2017, ANN ALLERG ASTHMA IM, V118, P80, DOI 10.1016/j.anai.2016.10.025
  26. Jerschow E, 2014, J ALLERGY CLIN IMMUN, V134, P1318, DOI 10.1016/j.jaci.2014.08.018
  27. Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591
  28. Jares EJ, 2015, J ALLER CL IMM-PRACT, V3, P780, DOI 10.1016/j.jaip.2015.05.012
  29. Karakaya G, 2013, RESP MED, V107, P967, DOI 10.1016/j.rmed.2013.03.014
  30. Kemp SF, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P33, DOI 10.1007/978-1-60327-951-2_3
  31. Kim YJ, 2014, ALLERGY ASTHMA IMMUN, V6, P156, DOI 10.4168/aair.2014.6.2.156
  32. Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200
  33. Kowalski ML, 2011, ALLERGY, V66, P818, DOI 10.1111/j.1398-9995.2011.02557.x
  34. Krishna MT, 2014, CLIN EXP IMMUNOL, V178, P399, DOI 10.1111/cei.12424
  35. Kuruvilla M, 2015, IMMUNOL ALLERGY CLIN, V35, P303, DOI 10.1016/j.iac.2015.01.008
  36. Lee YS, 2017, ACTA ANAESTHESIOL TA
  37. Leone R, 2005, DRUG SAFETY, V28, P547, DOI 10.2165/00002018-200528060-00006
  38. Lieberman P, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P1, DOI 10.1007/978-1-60327-951-2_1
  39. Liew WK, 2009, J ALLERGY CLIN IMMUN, V123, P434, DOI 10.1016/j.jaci.2008.10.049
  40. McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022
  41. Mertes PM, 2011, J INVEST ALLERG CLIN, V21, P442
  42. Munoz-Cano R, 2016, J INVEST ALLERG CLIN, V26, P73, DOI 10.18176/jiaci.0046
  43. Park HK, 2017, ALLERGOL INT
  44. Picard M, 2017, J ALLER CL IMM-PRACT, V5, P600, DOI 10.1016/j.jaip.2016.12.001
  45. Picard M, 2016, J ALLERGY CLIN IMMUN, V137, P1154, DOI 10.1016/j.jaci.2015.10.039
  46. Garcia AP, 2010, J INVEST ALLERG CLIN, V20, P170
  47. Pumphrey RSH, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P13, DOI 10.1007/978-1-60327-951-2_2
  48. Renaudin JM, 2013, ALLERGY, V68, P929, DOI 10.1111/all.12168
  49. Ribeiro-Vaz I, 2013, EUR J CLIN PHARMACOL, V69, P673, DOI 10.1007/s00228-012-1376-5
  50. Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303
  51. Simon RA, 2017, NSAIDS INCLUDING ASP
  52. Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1
  53. Simons FER, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-9
  54. Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c
  55. Sloane D, 2016, J ALLER CL IMM-PRACT, V4, P497, DOI 10.1016/j.jaip.2015.12.019
  56. Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051
  57. Tang MLK, 2009, CURR OPIN ALLERGY CL, V9, P351, DOI 10.1097/ACI.0b013e32832db95a
  58. Tanno LK, 2017, ALLERGY, V72, P120, DOI 10.1111/all.13006
  59. Techapornroong M, 2010, ASIAN PAC J ALLERGY, V28, P262
  60. VanDerKlauw MM, 1996, CLIN EXP ALLERGY, V26, P1355, DOI 10.1046/j.1365-2222.1996.d01-300.x
  61. Wang DY, 1998, PHARMACOEPIDEM DR S, V7, P269, DOI 10.1002/(SICI)1099-1557(199807/08)7:4<269::AID-PDS366>3.0.CO;2-3
  62. Yang MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005750